NASDAQ: HLNE
Hamilton Lane Inc Stock

$87.71+4.55 (+5.47%)
Updated Jul 27, 2026
HLNE Price
$87.71
Fair Value Price
$80.48
Market Cap
$4.87B
52 Week Low
$71.88
52 Week High
$161.13
P/E
14.64x
P/B
5.32x
P/S
7.3x
PEG
1.18x
Dividend Yield
2.53%
Revenue
$758.99M
Earnings
$249.18M
Gross Margin
100%
Operating Margin
44.71%
Profit Margin
32.8%
Debt to Equity
0.92
Operating Cash Flow
$425M
Beta
1.34
Next Earnings
Aug 4, 2026
Ex-Dividend
N/A
Next Dividend
N/A

HLNE Overview

Hamilton Lane Incorporated operates as an investment management firm, specializing in both direct investments and fund-of-funds strategies. The firm offers a comprehensive range of services, including: Tailored Separate Accounts: Structured as single-client vehicles, these are customized to meet specific client requirements. Specialized Investment Strategies: This category encompasses offerings such as fund-of-funds, secondary market transactions, co-investments, Taft-Hartley plans, and distribution management. Advisory Services: Hamilton Lane provides expert guidance, covering thorough due diligence, strategic portfolio planning, continuous monitoring, and performance reporting. Reporting and Analytics: The company also delivers advanced solutions for data reporting and analysis. For its direct investments, Hamilton Lane targets a diverse array of companies, participating across various stages of their lifecycle. This includes early, mid, and late-stage venture capital, mature businesses, and growth equity opportunities. The firm's interests also extend to emerging growth companies, distressed debt scenarios, later-stage financing, corporate turnarounds, bridge financing, mezzanine capital, and leveraged buyouts, primarily within the middle market segment. When pursuing a fund-of-funds approach, Hamilton Lane allocates capital to a variety of specialized funds. These include those focused on mezzanine, venture capital, private equity, turnaround, secondary investments, real estate, and special situations. Beyond specific asset classes, the firm's investment scope spans multiple sectors, including real estate, technology, healthcare, education, natural resources, energy, essential consumer goods, cleantech, environmental initiatives, community development, and financial empowerment projects. Geographically, Hamilton Lane's private equity investments demonstrate a wide global footprint, with its presence extending across North America (including the United States), Latin America, Western Europe (including the United Kingdom), the Middle East, Africa, Asia (including Japan), and Australia. The firm typically aims to commit between $1 million and $100 million per company, often prioritizing the acquisition of a majority ownership stake in its portfolio companies. Established in 1991, Hamilton Lane Incorporated maintains its headquarters in Conshohocken, Pennsylvania, complemented by a network of additional offices across Europe, North America, and Asia.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine HLNE's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More

Zen Rating Component Grades

B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Asset Management

Industry Rating
D
HLNE
Ranked
#37 of 79

Top Ranked Stocks in Industry

View Top Asset Management Stocks

Be the first to know about important HLNE news, forecast changes, insider trades & much more!

HLNE News

Overview

Due Diligence Score

Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HLNE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HLNE ($87.71) is overvalued by 8.98% relative to our estimate of its Fair Value price of $80.48 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
HLNE ($87.71) is not significantly undervalued (8.98%) relative to our estimate of its Fair Value price of $80.48 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
HLNE ($87.71) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more HLNE due diligence checks available for Premium users.

Valuation

HLNE fair value

Fair Value of HLNE stock based on Discounted Cash Flow (DCF)

Price
$87.71
Fair Value
$80.48
Overvalued by
8.98%
HLNE ($87.71) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HLNE ($87.71) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HLNE ($87.71) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HLNE price to earnings (PE)

For valuing profitable companies with steady earnings

Company
14.64x
Industry
33.26x
Market
14.17x
HLNE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HLNE is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

HLNE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
5.32x
Industry
2.8x
HLNE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HLNE price to earnings growth (PEG)

For valuing profitable companies with growth potential

HLNE is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

HLNE's financial health

Profit margin

Revenue
$193.6M
Net Income
$66.2M
Profit Margin
34.2%
HLNE's Earnings (EBIT) of $339.34M... subscribe to Premium to read more.
Interest Coverage Financials
HLNE's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.3B
Liabilities
$838.4M
Debt to equity
0.92
HLNE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HLNE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$103.0M
Investing
-$149.8M
Financing
$69.3M
HLNE's operating cash flow ($424.92M)... subscribe to Premium to read more.
Debt Coverage Financials

HLNE vs Asset Management Stocks

TickerZen RatingMarket Cap1d %P/EP/B
HLNEC$4.87B+5.47%14.64x5.32x
MAIND$5.00B+0.62%11.33x1.62x
FHIC$4.50B+2.24%11.50x3.73x
STEPC$5.33B+4.79%-6.59x-12.89x
BXSLC$5.35B-1.03%12.04x0.88x

Hamilton Lane Stock FAQ

What is Hamilton Lane's quote symbol?

(NASDAQ: HLNE) Hamilton Lane trades on the NASDAQ under the ticker symbol HLNE. Hamilton Lane stock quotes can also be displayed as NASDAQ: HLNE.

If you're new to stock investing, here's how to buy Hamilton Lane stock.

What is the 52 week high and low for Hamilton Lane (NASDAQ: HLNE)?

(NASDAQ: HLNE) Hamilton Lane's 52-week high was $161.13, and its 52-week low was $71.88. It is currently -45.57% from its 52-week high and 22.02% from its 52-week low.

How much is Hamilton Lane stock worth today?

(NASDAQ: HLNE) Hamilton Lane currently has 55,533,814 outstanding shares. With Hamilton Lane stock trading at $87.71 per share, the total value of Hamilton Lane stock (market capitalization) is $4.87B.

Hamilton Lane stock was originally listed at a price of $18.02 in Mar 1, 2017. If you had invested in Hamilton Lane stock at $18.02, your return over the last 9 years would have been 386.74%, for an annualized return of 19.22% (not including any dividends or dividend reinvestments).

How much is Hamilton Lane's stock price per share?

(NASDAQ: HLNE) Hamilton Lane stock price per share is $87.71 today (as of Jul 27, 2026).

What is Hamilton Lane's Market Cap?

(NASDAQ: HLNE) Hamilton Lane's market cap is $4.87B, as of Jul 28, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Hamilton Lane's market cap is calculated by multiplying HLNE's current stock price of $87.71 by HLNE's total outstanding shares of 55,533,814.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.